Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  OTC Bulletin Board - Other OTC  >  Eternity Healthcare, Inc.    ETAH

ETERNITY HEALTHCARE, INC.

(ETAH)
Delayed Quote. Delayed OTC Bulletin Board - Other OTC - 01/19 09:30:28 am
0.0004 USD   -77.78%
2018ETERNITY HEALTHCARE INC : SPLIT: 3.5 of 1
FA
2017Eternity Clears Product Development Hurdle
GL
2017Wellmei Mold of Hong Kong Chosen as Lenis® Nozzle Manufacturer for Eternity
GL
SummaryQuotesChartsNewsCompany 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Eternity Clears Product Development Hurdle

06/28/2017 | 09:31am EST

PHOENIX and VANCOUVER, British Columbia, June 28, 2017 (GLOBE NEWSWIRE) -- Eternity Healthcare Inc. (OTC:ETAH), announces it has resolved an earlier manufacturing issue affecting 10% of its syringes (nozzles) and resulting in a failure to obtain CE certification and approval. Preliminary testing of a number of nozzles, confirmed compliance with certification standards.

“We are pleased to sort out this final hurdle and look forward to CE auditors completing the inspection process for approval,” said Dr. Salari, President & CEO.

The Lenis® Needle-Free Injection system is comprised of four major components.  Currently two of the components have received CE certification and approval and now the third component shall be submitted for approval. We believe the remaining components shall get the approval soon.

Needle-Free Injection System Applications
The Needle-Free Injection system can be used for a vast variety of injectable medications, and supplements. These include injection of Insulin for diabetes, injection of vaccines such as flu vaccine and many others, injection of steroids, vitamins, human growth hormones, infertility medications, a vast number of cancer drugs, cosmetic fillers and a new version of epinephrine drugs such as, Mylan’s Epipen®.

About Eternity Healthcare
Eternity Healthcare or the “Company” (OTC:ETAH) is a medical device company with technologies known as Needle-Free Injection System (the Lenis®).  Our products are targeted for use by the healthcare professionals, physicians and consumers directly. For more information on Eternity Healthcare, visit the Company’s website; www.eternityhealthcare.com

Safe Harbor Statement
This release includes forward-looking statements. These statements generally can be identified by phrases such as "believes," "expects," "anticipates," "foresees," "forecasts," "estimates" or other words or phrases of similar import. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements.

Company Contact:			
Dr. Salari				
President & CEO
(604) 324 -1113
hassansalari@eternityhealthcare.com

Primary Logo


© GlobeNewswire 2017
All news about ETERNITY HEALTHCARE, INC.
2018ETERNITY HEALTHCARE INC : SPLIT: 3.5 of 1
FA
2017Eternity Clears Product Development Hurdle
GL
2017Wellmei Mold of Hong Kong Chosen as Lenis® Nozzle Manufacturer for Eternity
GL
2017Lenis® Receives Next Regulatory Certification
GL
2017Milestone Certification Achieved for Eternity Healthcare's Lenis® Device
GL
2016Eternity Healthcare Moves to Next Stage Regulatory Approval Phase with Lenis®
GL
More news
Chart ETERNITY HEALTHCARE, INC.
Duration : Period :
Eternity Healthcare, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Managers and Directors
NameTitle
Weitao Wang Chairman, President, CEO & CFO
Allen Yuan Investor Relations Contact
Sector and Competitors
1st jan.Capitalization (M$)
ETERNITY HEALTHCARE, INC.-20.00%0
GILEAD SCIENCES, INC.14.90%83 911
WUXI APPTEC CO., LTD.30.64%66 044
VERTEX PHARMACEUTICALS0.53%61 782
REGENERON PHARMACEUTICALS11.32%56 760
BEIGENE, LTD.44.94%34 148